The Measurement of Spine Dynamics During Gait for the Quantification of Intervention Outcomes in Patients With Different Pathologies
Shoe insole
+ Modified shoe with sole lift
+ Ankle foot orthosis
Maladies osseuses+8
+ Maladies Osseuses Développementales
+ Dommage Cérébral Chronique
Étude thérapeutique
Résumé
Date de début de l'étude : 1 juillet 2013
Date à laquelle le premier participant a commencé l'étude.Measuring spine dynamics is a necessity in order to better understand gait deviations throughout the whole body and to evaluate treatment effects on spinal movement during gait. However, the full body marker sets that are typically used in opto-electronic 3D gait analyses either disregard the spine entirely or regard it as a rigid structure. Therefore, the purpose of this study is to use an enhanced trunk marker set in order to evaluate the biomechanical effects of lower extremity treatments on spine dynamics in patients with different pathologies. It has been hypothesized that the enhanced trunk marker set is a reliable method for the measurement of spine dynamics during gait in patients with deviations occurring secondary to leg length inequality. the enhanced trunk marker set is a reliable method for the measurement of spine dynamics during gait in patients that present both primary and secondary deviations such as seen in hemiplegic and diplegic cerebral palsy. treatment by means of either a shoe insole or a modified shoe with sole lift on the shorter side has an effect on spine dynamics during gait in patients with leg length inequality. treatment by means of an ankle foot orthosis to control the foot position has an effect on spine dynamics during gait in patients with hemiplegic and diplegic cerebral palsy. To verify the hypotheses, instrumented gait analyses with a standard full body marker set and the enhanced trunk marker set will be carried out before and immediately after an orthotic lower extremity treatment in the respective patient group.
Protocole
Cette section fournit des détails sur le plan de l'étude, y compris la manière dont l'étude est conçue et ce qu'elle évalue.20 participants à inclure
Nombre total de participants que l'essai clinique vise à recruter.Traitement
Éligibilité
Les chercheurs recherchent des patients correspondant à une certaine description appelée critères d'éligibilité : état de santé général ou traitements antérieurs du patient.Tout sexe
Le sexe biologique des participants éligibles à s'inscrire.De 10 à 18 ans
Tranche d'âge des participants éligibles à participer.Volontaires sains non autorisés
Indique si les individus en bonne santé et ne présentant pas la condition étudiée peuvent participer.Conditions
Pathologie
Critères
Leg length inequality patients: Inclusion Criteria: Diagnosed structural leg length inequality (minimum 1% of body height) Several different aetiologies (except neurological) Able to walk a distance of minimum 50 meters without any assistive device Exclusion Criteria: Leg length inequality due to neurological aetiology Structural deformities of the spine Obesity (> 95th BMI-per-age percentile) Injuries of the locomotor system which led to persistent deformities Hemiplegic cerebral palsy patients: Inclusion Criteria: Diagnosed hemiplegic cerebral palsy (Gross Motor Function Classification System for Cerebral Palsy (GMFCS): Levels I and II) Able to walk a distance of minimum 50 meters barefoot and without any assistive device Exclusion Criteria: Structural deformities of the spine Any previous surgical and casting treatments as well as botulinumtoxin treatments within preceding 6 months. Obesity (> 95th BMI-per-age percentile) Injuries of the locomotor system which led to persistent deformities Diplegic cerebral palsy patients: Inclusion Criteria: Diagnosed diplegic cerebral palsy (Gross Motor Function Classification System for Cerebral Palsy (GMFCS): Levels I and II) Able to walk a distance of minimum 50 meters barefoot and without any assistive device Exclusion Criteria: Structural deformities of the spine Any previous surgical and casting treatments as well as botulinumtoxin treatments within preceding 6 months. Obesity (> 95th BMI-per-age percentile) Injuries of the locomotor system which led to persistent deformities
Plan de l'étude
Découvrez tous les traitements administrés dans cette étude, leur description détaillée et ce qu'ils impliquent.4 groupes d'intervention sont désignés dans cette étude
Cette étude ne comporte pas de groupe placebo.
Groupes de traitement
Groupe I
ExpérimentalGroupe II
ExpérimentalGroupe III
ExpérimentalGroupe IV
Pas d'interventionObjectifs de l'étude
Objectifs principaux
Objectifs secondaires
Centres d'étude
Ce sont les hôpitaux, cliniques ou centres de recherche où l'essai est conduit. Vous pouvez trouver le site le plus proche de vous ainsi que son statut.Cette étude comporte 1 site
University Children's Hospital Basel
Basel, SwitzerlandOuvrir University Children's Hospital Basel dans Google Maps